Cathie Wood: portfolio of ARK Investment Management

Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 12, 2025. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q3 2025. Go to the latest filing (Q3 2026)

16.8B USDQ3 2025
Total value of stock positions
16.8B USD
Positions
196
Share of the ten largest
46.2%

The ten largest positions Q3 2025

  1. Tesla, Inc. 9.5%▲ +16.6%
  2. Coinbase 4.8%▼ −8.7%
  3. Roku Inc 4.4%▼ −13.1%
  4. Palantir Technologies 4.4%▼ −1.0%
  5. Roblox 4.4%▼ −21.5%
  6. Robinhood Markets 4.3%▼ −35.6%
  7. Shopify 4.3%▼ −4.6%
  8. CRISPR Therapeutics AG 3.8%▼ −3.9%
  9. Tempus AI 3.4%▼ −3.3%
  10. Advanced Micro Devices 2.9%▲ +12.9%
Total value of stock positions per quarter, Q4 2016 to Q3 2026 (peak 53.7B USD).
Choose a quarter (40 filings)

All positions Q3 2025

Positions Q3 2025 per 13F filing, 74 of 74
Symbol Weight Shares Reported value Change Held since
COIN Coinbase 4.8% 2,395,540 808.5M USD −8.7% reduced Q2 2021 18 quarters
Roku Inc 4.4% 7,351,856 736.1M USD −13.1% reduced Q2 2019 26 quarters
PLTR Palantir Technologies 4.4% 4,035,093 736.1M USD −1.0% reduced Q2 2023 10 quarters
RBLX Roblox 4.4% 5,312,821 735.9M USD −21.5% reduced Q1 2021 19 quarters
HOOD Robinhood Markets 4.3% 5,017,044 718.3M USD −35.6% reduced Q3 2021 17 quarters
SHOP Shopify 4.3% 4,815,833 715.7M USD −4.6% reduced Q2 2017 34 quarters
CRISPR Therapeutics AG 3.8% 9,786,973 634.3M USD −3.9% reduced Q2 2017 34 quarters
TEM Tempus AI 3.4% 7,175,767 579.2M USD −3.3% reduced Q2 2024 6 quarters
Kratos Defense & Security Solu 2.0% 3,604,328 329.3M USD −20.0% reduced Q3 2018 29 quarters
ARK 21Shares Bitcoin ETF 1.4% 6,322,716 240.4M USD −4.5% reduced Q1 2024 7 quarters
Intellia Therapeutics Inc 1.2% 11,919,178 205.8M USD −8.4% reduced Q4 2016 or earlier 36 quarters
XYZ Block, Inc. 1.2% 2,673,415 193.2M USD −13.5% reduced Q4 2016 or earlier 36 quarters
Natera Inc 0.9% 892,593 143.7M USD −4.7% reduced Q1 2024 7 quarters
10X Genomics Inc 0.8% 11,887,396 139.0M USD −14.4% reduced Q2 2020 22 quarters
DKNG DraftKings 0.8% 3,438,916 128.6M USD −23.1% reduced Q1 2021 19 quarters
Guardant Health Inc 0.3% 795,234 49.7M USD −71.8% reduced Q3 2022 13 quarters
JOBY Joby Aviation 0.3% 3,010,461 48.6M USD −14.2% reduced Q3 2021 17 quarters
Adaptive Biotechnologies Corp 0.3% 3,165,636 47.4M USD −21.2% reduced Q2 2020 22 quarters
Ionis Pharmaceuticals Inc 0.2% 631,215 41.3M USD −29.9% reduced Q4 2016 or earlier 36 quarters
Pacific Biosciences of Califor 0.2% 30,924,103 39.6M USD −14.8% reduced Q3 2019 25 quarters
Schrodinger Inc/United States 0.2% 1,872,677 37.6M USD −4.4% reduced Q2 2020 22 quarters
Strata Critical Medical Inc 0.2% 6,404,585 32.4M USD −25.5% reduced Q2 2021 18 quarters
Genius Sports Limited 0.2% 2,430,125 30.1M USD −35.5% reduced Q3 2021 17 quarters
Cerus Corp 0.2% 18,850,188 30.0M USD −1.9% reduced Q4 2016 or earlier 36 quarters
Futu Holdings Ltd 0.1% 129,777 22.6M USD −0.5% reduced Q1 2025 3 quarters
OKLO Oklo Inc. 0.1% 156,481 17.5M USD −17.7% reduced Q3 2024 5 quarters
908 Devices Inc 0.1% 1,953,772 17.1M USD −26.2% reduced Q4 2020 20 quarters
Nurix Therapeutics Inc < 0.1% 1,510,404 14.0M USD −4.1% reduced Q4 2021 16 quarters
AMGN Amgen < 0.1% 47,265 13.3M USD −18.4% reduced Q1 2024 7 quarters
INCY Incyte < 0.1% 147,335 12.5M USD −4.1% reduced Q4 2016 or earlier 36 quarters
VEEV Veeva Systems < 0.1% 40,551 12.1M USD −18.7% reduced Q4 2020 20 quarters
Butterfly Network Inc < 0.1% 6,145,348 11.9M USD −4.2% reduced Q1 2021 19 quarters
Quantum-Si Inc < 0.1% 7,624,042 10.7M USD −4.2% reduced Q2 2021 18 quarters
REGN Regeneron Pharmaceuticals < 0.1% 12,142 6.8M USD −3.7% reduced Q4 2020 20 quarters
Stratasys Ltd < 0.1% 446,325 5.0M USD −4.8% reduced Q4 2016 or earlier 36 quarters
Xometry Inc < 0.1% 84,413 4.6M USD −30.7% reduced Q3 2021 17 quarters
Standard BioTools Inc < 0.1% 3,021,728 3.9M USD −4.2% reduced Q1 2024 7 quarters
PTC PTC Inc. < 0.1% 17,790 3.6M USD −6.5% reduced Q4 2016 or earlier 36 quarters
Proto Labs Inc < 0.1% 71,797 3.6M USD −9.7% reduced Q4 2016 or earlier 36 quarters
ADSK Autodesk < 0.1% 11,025 3.5M USD −16.2% reduced Q4 2016 or earlier 36 quarters
The 3D Printing ETF < 0.1% 142,696 3.3M USD −13.7% reduced Q1 2021 19 quarters
Gilat Satellite Networks Ltd < 0.1% 246,235 3.2M USD −7.7% reduced Q3 2020 21 quarters
Tower Semiconductor Ltd < 0.1% 39,638 2.9M USD −14.5% reduced Q4 2017 32 quarters
Materialise NV < 0.1% 505,829 2.8M USD −10.7% reduced Q4 2016 or earlier 36 quarters
UroGen Pharma Ltd < 0.1% 126,720 2.5M USD −23.7% reduced Q4 2017 32 quarters
Teva Pharmaceutical Industries < 0.1% 118,721 2.4M USD −1.8% reduced Q4 2017 32 quarters
Allot Ltd < 0.1% 226,442 2.3M USD −18.7% reduced Q1 2025 3 quarters
JFrog Ltd < 0.1% 47,390 2.2M USD −10.6% reduced Q1 2021 19 quarters
Nova Ltd < 0.1% 6,930 2.2M USD −26.2% reduced Q4 2017 32 quarters
Camtek Ltd < 0.1% 20,950 2.2M USD −23.5% reduced Q4 2017 32 quarters
SimilarWeb Ltd < 0.1% 230,053 2.1M USD −5.1% reduced Q3 2021 17 quarters
RADCOM Ltd < 0.1% 144,570 2.1M USD −2.3% reduced Q1 2025 3 quarters
Pagaya Technologies Ltd < 0.1% 66,533 2.0M USD −61.5% reduced Q1 2025 3 quarters
Magic Software Enterprises Ltd < 0.1% 91,821 1.9M USD −26.5% reduced Q1 2024 7 quarters
Taboola.com Ltd < 0.1% 530,584 1.8M USD −10.1% reduced Q1 2022 15 quarters
Radware Ltd < 0.1% 67,391 1.8M USD −13.8% reduced Q4 2017 32 quarters
AudioCodes Ltd < 0.1% 180,164 1.7M USD −1.5% reduced Q4 2017 32 quarters
Mobileye Global Inc < 0.1% 120,887 1.7M USD −11.8% reduced Q1 2023 11 quarters
Perion Network Ltd < 0.1% 171,322 1.6M USD −5.6% reduced Q4 2019 24 quarters
GE GE Aerospace < 0.1% 4,393 1.3M USD −13.1% reduced Q4 2016 or earlier 36 quarters
Valens Semiconductor Ltd < 0.1% 691,880 1.2M USD −1.2% reduced Q1 2025 3 quarters
Lincoln Electric Holdings Inc < 0.1% 5,148 1.2M USD −0.9% reduced Q3 2019 25 quarters
Kaiser Aluminum Corp < 0.1% 12,913 996.4K USD −23.2% reduced Q2 2019 26 quarters
iShares Ethereum Trust ETF < 0.1% 4,432 139.7K USD −29.7% reduced Q3 2024 5 quarters
Materion Corp < 0.1% 694 83.8K USD −23.0% reduced Q3 2024 5 quarters
DD DuPont < 0.1% 921 71.7K USD −17.8% reduced Q2 2019 26 quarters
Hexcel Corp < 0.1% 1,130 70.9K USD −16.5% reduced Q3 2017 33 quarters
MMM 3M < 0.1% 456 70.8K USD −15.4% reduced Q3 2018 29 quarters
Avient Corporation < 0.1% 2,119 69.8K USD −7.3% reduced Q3 2023 9 quarters
JBL Jabil < 0.1% 311 67.5K USD −41.2% reduced Q1 2024 7 quarters
Eastman Kodak Co < 0.1% 10,310 66.1K USD −7.3% reduced Q1 2021 19 quarters
Carpenter Technology Corp < 0.1% 241 59.2K USD −41.8% reduced Q4 2016 or earlier 36 quarters
Kennametal Inc < 0.1% 2,753 57.6K USD −19.0% reduced Q2 2025 2 quarters
Eastman Chemical Co < 0.1% 852 53.7K USD −7.2% reduced Q4 2016 or earlier 36 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Financials 15.8%
  • Technology 14.7%
  • Consumer Discretionary 12.2%
  • Industrials 4.2%
  • Communication Services 2.0%
  • Health Care 1.2%
  • not in our coverage 49.8%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close